Cardiovascular Pharmacology involves the study of how drugs interact with the cardiovascular system to produce their effects. These effects are typically characterized by changes in the function of the heart, blood vessels, and other components of the circulatory system. Pharmacodynamic considerations include the mechanisms by which drugs exert their influence, such as receptor interactions, signal transduction pathways, and alterations in cellular function.
For instance, beta-blockers act by blocking beta-adrenergic receptors, leading to reduced heart rate and contractility. Calcium channel blockers inhibit the entry of calcium ions into cardiac and smooth muscle cells, resulting in vasodilation and decreased cardiac contractility. Antiplatelet agents, like aspirin, interfere with platelet function to prevent blood clot formation.
Understanding pharmacodynamics is crucial in tailoring drug therapy for cardiovascular conditions, as it allows for precise targeting of specific pathways to achieve therapeutic effects while minimizing adverse reactions. It plays a vital role in optimizing treatment strategies for conditions such as hypertension, heart failure, and arrhythmias.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico